Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 20,73€(+72,75%). Der Median liegt bei 20,73€(+72,75%).
Kaufen | 12 |
Halten | 5 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 1 / 18 |
Levermann-Strategie | -4 / 13 |
News
CoreWeave: Market Hates A Good Deal
CoreWeave's acquisition of Core Scientific aims to verticalize data center ownership and cut $500 million in costs by 2027. The deal gives CoreWeave direct control over data center assets, enabling faster, tailored AI infrastructure deployments and improved cost efficiency. Despite operational benefits, the market reacted negatively, with CoreWeave shares dropping and the deal value for Core Scientific shareholders declining.» Mehr auf seekingalpha.com
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Core Scientific, Inc. (NASDAQ: CORZ)
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Core Scientific, Inc. (NASDAQ: CORZ ) related to its sale to CoreWeave, Inc. Upon completion of the proposed transaction, each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock. Core Scientific shareholders will own less than 10% of the combined company. Is it a fair deal?» Mehr auf globenewswire.com
CORE SCIENTIFIC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Core Scientific, Inc. - CORZ
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Core Scientific, Inc. (NasdaqGS: CORZ) to CoreWeave, Inc. (NasdaqGS: CRWV). Under the terms of the proposed transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific that they own. KSF is seeking to d.» Mehr auf businesswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 73,51 Mio | 55,75% |
Bruttoeinkommen | 7,59 Mio | 89,45% |
Nettoeinkommen | 536,77 Mio | 174,95% |
EBITDA | −39,37 Mio | 116,68% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 3,56 Mrd€ |
Anzahl Aktien | 303,69 Mio |
52 Wochen-Hoch/Tief | 16,09€ - 5,36€ |
Dividenden | Nein |
Beta | 6,74 |
KGV (PE Ratio) | −4,52 |
KGWV (PEG Ratio) | −0,51 |
KBV (PB Ratio) | −23,55 |
KUV (PS Ratio) | 10,02 |
Unternehmensprofil
Name | CORE SCIENTIFIC |
CEO | Adam Sullivan |
Sitz | Dover, tx USA |
Website | |
Industrie | IT-Dienste |
Mitarbeiter | 325 |
Assets entdecken
Shareholder von CORE SCIENTIFIC investieren auch in folgende Assets